Tetralogy of Fallot With Pulmonary Atresia Treatment & Management

  • Author: Michael D Pettersen, MD; Chief Editor: Stuart Berger, MD   more...
 
Updated: Aug 23, 2011
 

Surgical Intervention

Neonates with adequate-sized confluent pulmonary arteries may be amenable to primary definitive surgical repair. A palliative procedure with a systemic–to–pulmonary artery shunt may be performed while awaiting complete repair at a later date. The ultimate surgical goals are: (1) to incorporate as many pulmonary artery segments as possible into a pulmonary artery confluence, (2) to place a conduit from the right ventricle to the pulmonary artery confluence, and (3) to close the ventricular septal defect (VSD).

Hypoplastic pulmonary arteries

When the pulmonary arteries are hypoplastic, nonconfluent, and supplied by aortopulmonary collaterals, a multistaged repair is often required.[17] Hypoplastic pulmonary arteries generally require palliative shunting to induce enlargement and growth of these vessels so they can be successfully incorporated into the complete repair. The shunts used may be modified Blalock-Taussig or central shunts and may be unilateral or bilateral. Another important strategy to maximize the long-term outcome in this group of patients is the early unifocalization of as many of the aortopulmonary collaterals as possible into a central pulmonary artery confluence.[18, 19] This maximizes the recruitment of lung segments and increases the likelihood of performing the definitive repair.

Complete repair following palliation

For complete repair to be performed in a child who has undergone palliation: (1) The central pulmonary arterial area must be greater than 50% of normal; (2) predominantly left-to-right intracardiac shunting must be present; (3) the equivalent of an entire lung must be supplied by the central pulmonary artery confluence; and (4) stenotic lesions in the pulmonary artery outflow must be addressed.

The choice of the optimal type of conduit for a growing child remains controversial. Current options include cryopreserved aortic or pulmonary homografts, glutaraldehyde fixed bovine jugular vein grafts, and synthetic conduits, with variable intermediate-term results reported in the medical literature.[20, 21, 22] Patients with membranous pulmonary atresia may be amenable to repair using a pulmonary transannular patch. These patients have an improved freedom from reintervention compared with patients who receive right ventricle-to-pulmonary artery conduit.[23]

Significant pulmonic valve regurgitation often occurs regardless of the type of conduit placed between the right ventricle and the pulmonary arteries. Some patients develop substantial right ventricular dilation and right ventricular dysfunction. Surgical placement of a pulmonic valve may significantly benefit these patients. More recently, a transcatheter-placed pulmonary valve comprising a valved segment of bovine jugular vein sewn within a balloon-expandable stent has been made commercially available. This valve can be placed in patients with postoperative conduit dysfunction consisting of pulmonary regurgitation, obstruction, or both. Early results with this valve suggest a high rate of procedural success and encouraging short-term valve function.[24]

Single-stage repair

Some centers have shifted toward performing a single-stage repair, wherein all the multiple aortopulmonary collaterals (MAPCAs) are ligated at the aorta.[25, 26] These MAPCAs are then mobilized toward the posterior mediastinum to construct a pulmonary artery confluence, followed by insertion of a pulmonary allograft to establish continuity between these neopulmonary arteries and the right ventricle. The ventricular septal defect (VSD) is closed.

These centers have reported good results. Infants with postunifocalization pulmonary arteries that, combined, are only mildly hypoplastic (> 200 mm2/m2) have a lower mortality rate and acceptable right ventricular pressures. However, most patients require repeat catheterizations for balloon dilation or stent placements in stenotic pulmonary artery segments to alleviate elevated right ventricular pressures.

Next

Consultations

The following consultations are advised:

  • Pediatric cardiology consultation
  • Geneticist consultation to evaluate the presence of syndromic associations and gene deletions, especially in the presence of associated anomalies or dysmorphic features
  • Cardiovascular surgical consultation, once the anatomy of a child with tetralogy of Fallot with pulmonary atresia (TOF-PA) is determined by echocardiography and angiography findings (see Workup);the caregivers need to be aware of the possibility of a multistage repair and repeated surgeries and catheterizations
  • Consultations and follow-up with the appropriate specialists for anomalies involving other systems
Previous
Next

Long-Term Monitoring

Infants with multiple aortopulmonary collaterals may require outpatient medical management of heart failure.

Residual right ventricular hypertension with right ventricular dysfunction from hypoplastic pulmonary arteries may be present.

After each stage of surgical reconstruction, echocardiographic and Doppler ultrasonic evaluation of hemodynamic adequacy should be performed. After complete repair, the patient needs to be evaluated for the development of right ventricle–to–pulmonary artery conduit stenosis as well as pulmonic regurgitation.

Some patients may never reach the stage of complete repair because of very hypoplastic pulmonary arteries. These patients often are hypoxemic and polycythemic and may require oxygen supplementation. Patients who are chronically cyanotic should be carefully monitored for complications related to polycythemia and iron deficiency anemia.

Previous
Next

Approach Considerations

Admit patients with tetralogy of Fallot with pulmonary atresia (TOF-PA) for testing and surgical intervention. Transfer to a tertiary care center is indicated for complete diagnostic evaluation and surgical intervention.

Newborn infants with cyanosis due to congenital heart disease almost always benefit from administration of prostaglandin E1 (PGE1) to maintain ductal patency while a definitive diagnosis is made. Once the diagnosis of tetralogy of Fallot with pulmonary atresia (TOF-PA) is made, maintain PGE1 infusion through the initial surgery.

Older infants with increased pulmonary blood flow may require treatment for heart failure.

All patients with tetralogy of Fallot with pulmonary atresia are required to take appropriate antibiotic bacterial endocarditis prophylaxis.

Nutritional support

Infants who are born with multiple systemic-to-pulmonary collaterals and are in cardiac failure because of pulmonary overcirculation require caloric supplementation to establish a normal growth pattern. Caloric intake as high as 130-150 kcal/kg/d may be required to ensure adequate growth.

Children that undergo palliative procedures also require optimization of their caloric intake. Adequate nutritional supplementation in the form of total parental nutrition must also be ascertained in the perioperative period. These patients often have a prolonged postoperative recovery course.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Michael D Pettersen, MD  Director of Echocardiography, Division of Cardiology, Children's Hospital of Michigan; Associate Professor of Pediatrics, Wayne State University School of Medicine

Michael D Pettersen, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, and American Society of Echocardiography

Disclosure: Nothing to disclose.

Specialty Editor Board

Ira H Gessner, MD  Professor Emeritus, Pediatric Cardiology, University of Florida College of Medicine

Ira H Gessner, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Ameeta Martin, MD  Clinical Associate Professor, Department of Pediatric Cardiology, University of Nebraska College of Medicine

Ameeta Martin, MD is a member of the following medical societies: American College of Cardiology

Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD  Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin

Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Aparna Kulkarni, MBBS, MD, to the development and writing of the source article.

References
  1. Tchervenkov CI, Roy N. Congenital Heart Surgery Nomenclature and Database Project: pulmonary atresia--ventricular septal defect. Ann Thorac Surg. Apr 2000;69(4 Suppl):S97-105. [Medline].

  2. Perry LW, Neill CA, Ferencz C. Infants with congenital heart disease: the cases. In: Ferencz C, Rubin JD, Loffredo CA, et al. Perspectives in Pediatric Cardiology: Epidemiology of Congenital Heart Disease. Armonk, NY: The Baltimore Washington Infant study; 1997:59-102.

  3. Van Praagh R, Van Praagh S, Nebesar RA, et al. Tetralogy of Fallot: underdevelopment of the pulmonary infundibulum and its sequelae. Am J Cardiol. Jul 1970;26(1):25-33. [Medline].

  4. Marino B, Digilio MC, Toscano A, et al. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet Med. Jan-Feb 2001;3(1):45-8. [Medline].

  5. Carotti A, Digilio MC, Piacentini G, Saffirio C, Di Donato RM, Marino B. Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome. Dev Disabil Res Rev. 2008;14(1):35-42. [Medline].

  6. Digilio MC, Marino B, Grazioli S, et al. Comparison of occurrence of genetic syndromes in ventricular septal defect with pulmonic stenosis (classic tetralogy of Fallot) versus ventricular septal defect with pulmonic atresia. Am J Cardiol. Jun 15 1996;77(15):1375-6. [Medline].

  7. Bertranou EG, Blackstone EH, Hazelrig JB, et al. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol. Sep 1978;42(3):458-66. [Medline].

  8. Leonard H, Derrick G, O'Sullivan J, Wren C. Natural and unnatural history of pulmonary atresia. Heart. Nov 2000;84(5):499-503. [Medline].

  9. Marrelli AJ, Perloff JK, Child JS, Laks H. Pulmonary atresia with ventricular septal defect in adults. Circulation. 1994;89(1):243-51. [Medline].

  10. Dearani JA, Danielson GK, Puga FJ, et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg. Feb 2003;75(2):399-410; discussion 410-1. [Medline].

  11. Mohammadi S, Belli E, Martinovic I, et al. Surgery for right ventricle to pulmonary artery conduit obstruction: risk factors for further reoperation. Eur J Cardiothorac Surg. Aug 2005;28(2):217-22. [Medline].

  12. Geva T, Greil GF, Marshall AC, et al. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation. Jul 23 2002;106(4):473-8. [Medline]. [Full Text].

  13. Bernardes RJ, Marchiori E, Bernardes PM, Monzo Gonzaga MB, Simoes LC. A comparison of magnetic resonance angiography with conventional angiography in the diagnosis of tetralogy of Fallot. Cardiol Young. Jun 2006;16(3):281-8. [Medline].

  14. Rajeshkannan R, Moorthy S, Sreekumar KP, Ramachandran PV, Kumar RK, Remadevi KS. Role of 64-MDCT in evaluation of pulmonary atresia with ventricular septal defect. AJR Am J Roentgenol. Jan 2010;194(1):110-8. [Medline].

  15. Mackie AS, Gauvreau K, Perry SB, et al. Echocardiographic predictors of aortopulmonary collaterals in infants with tetralogy of fallot and pulmonary atresia. J Am Coll Cardiol. Mar 5 2003;41(5):852-7. [Medline].

  16. Mair DD, Julsrud PR. Diagnostic evaluation of pulmonary atresia and ventricular septal defect cardiac catheterization and angiography. Prog Pediatr Cardiol. 1992;1(1):23-26.

  17. Duncan BW, Mee RB, Prieto LR, et al. Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg. Sep 2003;126(3):694-702. [Medline].

  18. Davies B, Mussa S, Davies P, Stickley J, Jones TJ, Barron DJ. Unifocalization of major aortopulmonary collateral arteries in pulmonary atresia with ventricular septal defect is essential to achieve excellent outcomes irrespective of native pulmonary artery morphology. J Thorac Cardiovasc Surg. Dec 2009;138(6):1269-75.e1. [Medline].

  19. Malhotra SP, Hanley FL. Surgical management of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals: a protocol-based approach. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009;145-51. [Medline].

  20. Sierra J, Christenson JT, Lahlaidi NH, Beghetti M, Kalangos A. Right ventricular outflow tract reconstruction: what conduit to use? Homograft or Contegra?. Ann Thorac Surg. Aug 2007;84(2):606-10; discussion 610-1. [Medline].

  21. Niemantsverdriet MB, Ottenkamp J, Gauvreau K, Del Nido PJ, Hazenkamp MG, Jenkins KJ. Determinants of right ventricular outflow tract conduit longevity: a multinational analysis. Congenit Heart Dis. May 2008;3(3):176-84. [Medline].

  22. Belli E, Salihoglu E, Leobon B, Roubertie F, Ly M, Roussin R, et al. The performance of Hancock porcine-valved Dacron conduit for right ventricular outflow tract reconstruction. Ann Thorac Surg. Jan 2010;89(1):152-7; discussion 157-8. [Medline].

  23. Kaza AK, Lim HG, Dibardino DJ, Bautista-Hernandez V, Robinson J, Allan C, et al. Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: options and outcomes. J Thorac Cardiovasc Surg. Oct 2009;138(4):911-6. [Medline].

  24. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. Aug 3 2010;122(5):507-16. [Medline].

  25. Lofland GK. The management of pulmonary atresia, ventricular septal defect, and multiple aorta pulmonary collateral arteries by definitive single stage repair in early infancy. Eur J Cardiothorac Surg. Oct 2000;18(4):480-6. [Medline].

  26. Reddy VM, Petrossian E, McElhinney DB, et al. One-stage complete unifocalization in infants: when should the ventricular septal defect be closed?. J Thorac Cardiovasc Surg. May 1997;113(5):858-66; discussion 866-8. [Medline].

Previous
Next
 
Parasternal long axis two-dimensional echocardiographic image demonstrating a large malalignment ventricular septal defect with overriding of the aorta over the ventricular septum.
Subcostal sagittal plane two-dimensional echocardiographic image showing pulmonary valve atresia, with confluent and well-developed pulmonary artery branches.
Suprasternal long axis color flow echocardiographic image showing a large patent ductus arteriosus supply confluent pulmonary arteries.
Aortopulmonary view angiogram, with injection in the descending thoracic aorta demonstrating multiple aortopulmonary collaterals supplying pulmonary blood flow.
Parasternal long axis two-dimensional echocardiographic image in a patient status post complete repair of tetralogy of Fallot with pulmonary atresia. A patch is visualized closing the ventricular septal defect.
Parasternal long axis color compare echocardiographic image showing the pulmonary artery conduit arising from the right ventricle.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.